Advances in treatment of Vogt-Koyanagi-Harada syndrome
Vogt-Koyanagi-Harada(VKH)syndrome is an autoimmune disease attacking against pigmented cells, resulting in blindness and usually affecting multiple organs including ears, meninges, hair and skin. Correct diagnosis and immediate treatment in the early stage is vital to visual prognosis. Currently, co...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2017-06-01
|
| Series: | Guoji Yanke Zazhi |
| Subjects: | |
| Online Access: | http://ies.ijo.cn/cn_publish/2017/6/201706018.pdf |
| _version_ | 1819128259741220864 |
|---|---|
| author | Guo Huang Pei-Zeng Yang |
| author_facet | Guo Huang Pei-Zeng Yang |
| author_sort | Guo Huang |
| collection | DOAJ |
| description | Vogt-Koyanagi-Harada(VKH)syndrome is an autoimmune disease attacking against pigmented cells, resulting in blindness and usually affecting multiple organs including ears, meninges, hair and skin. Correct diagnosis and immediate treatment in the early stage is vital to visual prognosis. Currently, corticosteroids is first-line drug. In addition, VKH patients refractory to corticosteroids can choose other treatment such as immunosuppressive agents and biological agents. |
| first_indexed | 2024-12-22T08:24:59Z |
| format | Article |
| id | doaj.art-4fb84533a1d546e396419c81141760b2 |
| institution | Directory Open Access Journal |
| issn | 1672-5123 1672-5123 |
| language | English |
| last_indexed | 2024-12-22T08:24:59Z |
| publishDate | 2017-06-01 |
| publisher | Press of International Journal of Ophthalmology (IJO PRESS) |
| record_format | Article |
| series | Guoji Yanke Zazhi |
| spelling | doaj.art-4fb84533a1d546e396419c81141760b22022-12-21T18:32:39ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51231672-51232017-06-011761082108610.3980/j.issn.1672-5123.2017.6.18Advances in treatment of Vogt-Koyanagi-Harada syndromeGuo Huang0Pei-Zeng Yang1Department of Ophthalmology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Lab of Ophthalmology, Chongqing Eye Institute, Chongqing 400016, ChinaDepartment of Ophthalmology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Lab of Ophthalmology, Chongqing Eye Institute, Chongqing 400016, ChinaVogt-Koyanagi-Harada(VKH)syndrome is an autoimmune disease attacking against pigmented cells, resulting in blindness and usually affecting multiple organs including ears, meninges, hair and skin. Correct diagnosis and immediate treatment in the early stage is vital to visual prognosis. Currently, corticosteroids is first-line drug. In addition, VKH patients refractory to corticosteroids can choose other treatment such as immunosuppressive agents and biological agents.http://ies.ijo.cn/cn_publish/2017/6/201706018.pdfVogt-Koyanagi-Harada syndromecorticosteroidsimmunosuppressive agentbiological agentbiological agent |
| spellingShingle | Guo Huang Pei-Zeng Yang Advances in treatment of Vogt-Koyanagi-Harada syndrome Guoji Yanke Zazhi Vogt-Koyanagi-Harada syndrome corticosteroids immunosuppressive agent biological agent biological agent |
| title | Advances in treatment of Vogt-Koyanagi-Harada syndrome |
| title_full | Advances in treatment of Vogt-Koyanagi-Harada syndrome |
| title_fullStr | Advances in treatment of Vogt-Koyanagi-Harada syndrome |
| title_full_unstemmed | Advances in treatment of Vogt-Koyanagi-Harada syndrome |
| title_short | Advances in treatment of Vogt-Koyanagi-Harada syndrome |
| title_sort | advances in treatment of vogt koyanagi harada syndrome |
| topic | Vogt-Koyanagi-Harada syndrome corticosteroids immunosuppressive agent biological agent biological agent |
| url | http://ies.ijo.cn/cn_publish/2017/6/201706018.pdf |
| work_keys_str_mv | AT guohuang advancesintreatmentofvogtkoyanagiharadasyndrome AT peizengyang advancesintreatmentofvogtkoyanagiharadasyndrome |